Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients
暂无分享,去创建一个
U. Jaeger | G. Parry | C. Sillaber | S. Panicker | B. Jilma | G. Patou | T. Schenk | C. Schoergenhofer | J. Gilbert | P. Jilma-Stohlawetz | J. Bartko | M. Fillitz | S. D’Sa